Is Bedaquiline (Snaery) a free national drug?

Bedaquiline (Bedaquiline) is a drug used to treat multidrug-resistant tuberculosis (MDR-TB), but it is not a national free drug in China. However, Bedaquiline (Snaery) has been launched in China and has been included in medical insurance, which means that eligible patients can obtain part or all of the drug cost reimbursement through medical insurance reimbursement.

According to the current price information, Bedaquiline (Sneril) specification is 100 mg *24 tablets, and the price is about four to five thousand yuan. Specific prices and medical insurance reimbursement may vary by region, and patients can obtain detailed information by consulting the local hospital pharmacy or medical insurance department. The scope and standards of medical insurance reimbursement are usually determined by local medical insurance policies and regulations. Qualified patients can obtain a certain percentage of cost reimbursement or reduction according to relevant regulations.

In comparison, abroad, especially in Russia, the price of bedaquiline (Sneril) is relatively low. The Russian version of the original drug has a specification of 100mg*188 tablets, and the price is about more than 10,000 yuan. Although the price is much cheaper than the domestic Bedaquiline (Snery) , it should be noted that, whether domestic or foreign, Bedaquiline (Snery) , as an original drug, has exactly the same efficacy.

Although Bedaquiline (Sneril) is not a free national drug in China, it has been included in medical insurance, providing patients with a certain degree of financial compensation. In addition, the relatively low price and medical insurance reimbursement policy also provide patients with more choices and help, especially for those patients who need long-term treatment with Bedaquiline (Snaery), which can reduce the financial burden and improve the accessibility and sustainability of treatment.